Experts on their own experiences: the rise of patient-reported outcomes in oncology drug trials.
Publication
, Journal Article
LeBlanc, TW
Published in: Leuk Lymphoma
November 2019
Duke Scholars
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
November 2019
Volume
60
Issue
11
Start / End Page
2604 / 2605
Location
United States
Related Subject Headings
- Patient Reported Outcome Measures
- Medical Oncology
- Immunology
- Humans
- Hodgkin Disease
- Antibodies, Monoclonal, Humanized
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
LeBlanc, T. W. (2019). Experts on their own experiences: the rise of patient-reported outcomes in oncology drug trials. Leuk Lymphoma, 60(11), 2604–2605. https://doi.org/10.1080/10428194.2019.1632446
LeBlanc, Thomas W. “Experts on their own experiences: the rise of patient-reported outcomes in oncology drug trials.” Leuk Lymphoma 60, no. 11 (November 2019): 2604–5. https://doi.org/10.1080/10428194.2019.1632446.
LeBlanc TW. Experts on their own experiences: the rise of patient-reported outcomes in oncology drug trials. Leuk Lymphoma. 2019 Nov;60(11):2604–5.
LeBlanc, Thomas W. “Experts on their own experiences: the rise of patient-reported outcomes in oncology drug trials.” Leuk Lymphoma, vol. 60, no. 11, Nov. 2019, pp. 2604–05. Pubmed, doi:10.1080/10428194.2019.1632446.
LeBlanc TW. Experts on their own experiences: the rise of patient-reported outcomes in oncology drug trials. Leuk Lymphoma. 2019 Nov;60(11):2604–2605.
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
November 2019
Volume
60
Issue
11
Start / End Page
2604 / 2605
Location
United States
Related Subject Headings
- Patient Reported Outcome Measures
- Medical Oncology
- Immunology
- Humans
- Hodgkin Disease
- Antibodies, Monoclonal, Humanized
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences